Rare diseases
Investigational molecules
Locations
Back to Germany1 819 clinical trials in Potsdam, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
GermanyEfficacy and Safety of Petrelintide in Adults with Overweight or Obesity and Type 2 Diabetes: A Phase III Randomized Placebo‑Controlled Trial
GermanySafety and Efficacy of Oral Brepocitinib in Adults with Lichen Planopilaris: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2/3 Study
GermanyEfficacy and Safety of Rezpegaldesleukin (NKTR-358) in Patients Aged 12 Years and Older with Moderate-to-Severe Atopic Dermatitis
GermanyEfficacy and Safety of Rezpegaldesleukin (NKTR-358) in Patients Aged ≥12 Years with Moderate-to-Severe Atopic Dermatitis
GermanyStudy of gsk5733584 with bevacizumab versus standard drug combination in patients with platinum-sensitive ovarian cancer
GermanyLong‑term Safety and Tolerability of Anifrolumab in Adults with Systemic Lupus Erythematosus Who Completed Prior Study
GermanyStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
GermanyStudy of Once‑Weekly Eloralintide (LY3841136 Sodium) in Adults with Obesity or Overweight, Type 2 Diabetes, and High Cardiovascular Risk
GermanyPhase 3 Randomized Double‑Blind Study of Pitolisant versus Placebo for Safety and Efficacy in Adults with Idiopathic Hypersomnia
GermanyEffect of laroprovstat/rosuvastatin combination versus laroprovstat, rosuvastatin, and placebo on LDL‑C in hypercholesterolemia patients not previously treated with lipid‑lowering therapy
GermanyStudy of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer treatments, including studies for triple-negative, HER2-positive, and hormone receptor-positive variants. Research encompasses new combination therapies and targeted treatments.
Multiple studies are evaluating novel drug combinations and personalized therapeutic approaches.
Clinical research targeting various skin conditions, including atopic dermatitis and chronic skin disorders. Studies focus on both topical and systemic treatments.
Investigations include both traditional and innovative therapeutic approaches for skin conditions.
Studies focusing on multiple sclerosis treatment options, evaluating new medications and comparing their effectiveness to existing therapies.
Research aims to improve treatment outcomes and quality of life for patients with neurological conditions.
Research focusing on cardiovascular disease management and innovative treatments for related conditions, including studies on lipid management.
Trials aim to reduce major cardiovascular events and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
